Twist Bioscience, Sophia Genetics partner on NGS, DNA analysis

By staff writers

February 26, 2020 -- Twist Bioscience and Sophia Genetics are working together on next-generation sequencing (NGS) and DNA analysis powered by artificial intelligence (AI).

South San Francisco, CA-based Twist has developed a DNA synthesis platform that involves manufacturing synthetic DNA for use in NGS preparation and the development of antibody libraries that inform drug discovery. Sophia Genetics, which has offices in the U.S., Switzerland, and France, has developed an AI-powered platform for DNA analysis.

The collaboration will combine Twist's NGS enrichment solutions with Sophia's advanced DNA testing for use in somatic and germline testing, Twist said.

"Together, the technologies will allow a customer to go from sample to interpretation of the results quickly and efficiently," the company said in a statement.

Whole exome sequencing not always what it's cracked up to be
Depending on the reporting lab, whole exome sequencing test results may be incomplete and falsely reassuring if negative, according to a small study published...
Labs gear up to meet demand for genetic testing
Genetic testing and gene sequencing represent a paradigm shift in testing, but labs still have some time to develop a winning strategy for adapting to...
AMP highlights: Products aim to beat the clock in cancer detection
Cancer was a key focus at the recent Association for Molecular Pathology (AMP) annual meeting in Baltimore -- particularly faster detection and treatment...

Copyright © 2020

Last Updated np 2/26/2020 12:13:48 PM